Monitor for further share sales by mDR Ltd, as the reduction from prior holdings may signal gradual exit. Any conversion to a 13D filing would indicate activist intent.
Price Chart
Executive Summary
mDR Ltd filed an amended Schedule 13G disclosing a 9.984% passive stake in CytoMed Therapeutics as of October 12, 2026, based on 1,191,523 ordinary shares. The filing indicates mDR sold 145,400 shares between December 2024 and October 2026, reducing its position from prior levels. No financial figures beyond the stake percentage and share count are available from the document.
Key Financial Metrics
Key Facts
- mDR Ltd holds 1,191,523 ordinary shares of CytoMed Therapeutics, representing 9.984% of shares outstanding as of June 30, 2026.
- The stake includes shares acquired via subscription (747,414 shares) and conversion of a convertible loan (589,509 shares), partially offset by sales of 145,400 shares between December 2024 and October 2026.
- The filing is an amendment to a Schedule 13G, indicating passive investment intent.
- The filing date is October 23, 2026, with the event date of October 12, 2026.
Financial Impact
Stake valued at approximately $1.19 million based on historical acquisition cost; no current market value provided.
Risk Factors
- Continued selling by mDR Ltd could pressure the stock.
- Passive filing status limits near-term catalyst from this holder.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001477932-26-006422 |
| Document: 0001477932-26-006422-index.html | 0001477932-26-006422 |
| Document: 0001477932-26-006422.txt | 0001477932-26-006422 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | SC 13G/A | $0.9190 $0.9262 | ▲ +0.78% | ▲ +0.07% | $0.8900 (−3.16%) |
Oct 16, 2026 11d ago | SC 13D/A | $0.8799 $0.8520 | ▼ −3.17% | ▼ −3.59% | $0.8900 (+1.15%) |
Oct 13, 2026 14d ago | SC 13D/A | $0.8700 $0.8599 | ▼ −1.16% | ▼ −0.08% | $0.8900 (+2.30%) |
Oct 9, 2026 18d ago | 6-K | $0.8114 $0.8700 | ▼ −7.22% | ▼ −7.23% | $0.8900 (−9.69%) |
Sep 30, 2026 27d ago | 6-K | $0.8430 $0.8999 | ▼ −6.75% | ▼ −6.57% | $0.8900 (−5.58%) |
May 15, 2026 23w ago | 6-K | $1.16 $1.21 | ▲ +4.31% | ▲ +4.37% | $0.8900 (−23.28%) |
May 11, 2026 24w ago | 6-K | $0.8090 $0.7690 | ▼ −4.94% | ▼ −4.81% | $0.8900 (+10.01%) |
Mar 31, 2026 30w ago | 6-K | $1.00 $1.03 | ▲ +3.00% | ▲ +2.25% | $0.8900 (−11.00%) |
Mar 31, 2026 30w ago | 20-F | $1.00 $1.03 | ▲ +3.00% | ▲ +2.25% | $0.8900 (−11.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers